0001237899-13-000011.txt : 20130107
0001237899-13-000011.hdr.sgml : 20130107
20130107100251
ACCESSION NUMBER: 0001237899-13-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130104
FILED AS OF DATE: 20130107
DATE AS OF CHANGE: 20130107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13514011
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-01-04
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2013-01-04
4
M
0
2260.0
33.42
A
2260.0
D
Common Stock
2013-01-04
4
S
0
2260.0
181.22
D
0.0
D
Common Stock
2013-01-04
4
M
0
2740.0
33.42
A
2740.0
D
Common Stock
2013-01-04
4
S
0
2740.0
180.5
D
0.0
D
Non-Qualified Stock Option (right to buy)
33.42
2013-01-04
4
M
0
2260.0
D
2021-01-03
Common Stock
2260.0
7740.0
D
Non-Qualified Stock Option (right to buy)
33.42
2013-01-04
4
M
0
2740.0
D
2021-01-03
Common Stock
2740.0
5000.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 2,260 shares of Company stock on January 4, 2013 at prices ranging from $181.09 to $181.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price.
Represents volume-weighted average price of sales of 2,740 shares of Company stock on January 4, 2013 at prices ranging from $180.10 to $180.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Joseph L. Goldstein
2013-01-07